Janux Therapeutics | Novel T Cell Immunotherapies tech stack
Janux Therapeutics | Novel T Cell Immunotherapies works mostly with GCP. Its stack also includes GCP. GCP is named in 6 of the 12 job postings Janux Therapeutics | Novel T Cell Immunotherapies published in the last 12 months (50%). Counted by Alion from the job postings of Janux Therapeutics | Novel T Cell Immunotherapies, updated Oct 30, 2026.
What cloud and platforms does Janux Therapeutics | Novel T Cell Immunotherapies use?
GCP is named in 50% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies.
GCP
6 50%
What developer tools does Janux Therapeutics | Novel T Cell Immunotherapies use?
Microsoft Excel is named in 17% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies, followed by GraphPad Prism (8%).
Which engineering practices does Janux Therapeutics | Novel T Cell Immunotherapies ask for?
GMP is named in 25% of job postings at Janux Therapeutics | Novel T Cell Immunotherapies, followed by Good Clinical Practice (17%), Bioreactors (8%), Cell Culture (8%).
Show all (9)
How does your stack fit Janux Therapeutics | Novel T Cell Immunotherapies?
How is the Janux Therapeutics | Novel T Cell Immunotherapies stack changing?
Read from the dates of the postings themselves: a technology is new when the first posting that names it appeared in the last six months, rising or falling when its share of postings moved between the last two quarters.
How modern is the Janux Therapeutics | Novel T Cell Immunotherapies stack?
Janux Therapeutics | Novel T Cell Immunotherapies scores 51 out of 100 (Established). The score averages how current each technology in the stack is and adds weight for AI adoption. AI technologies in the stack: 0; legacy ones: 0.
How common is the Janux Therapeutics | Novel T Cell Immunotherapies stack in its industry?
Share of the 182 companies in the same industries, whose stack Alion knows, that use each technology.
Companies with a stack like Janux Therapeutics | Novel T Cell Immunotherapies
Secretome Therapeutics
7 shared technologies
o2h group
6 shared technologies
Dispatch Bio
11 shared technologies
Kernal Biologics
6 shared technologies
Marea Therapeutics
6 shared technologies
Pandorum
7 shared technologies
viridiusLAB
6 shared technologies
Pivotal Life Sciences
6 shared technologies
Questions about the Janux Therapeutics | Novel T Cell Immunotherapies tech stack
Does Janux Therapeutics | Novel T Cell Immunotherapies use GCP?
Yes. GCP is named in 6 of 12 job postings (50%) and required in 6 of them.
What cloud and platforms does Janux Therapeutics | Novel T Cell Immunotherapies use?
The cloud and platforms named in Janux Therapeutics | Novel T Cell Immunotherapies job postings are GCP (6) (postings in brackets).
Is the Janux Therapeutics | Novel T Cell Immunotherapies tech stack changing?
Yes. GMP, Microsoft Excel first appeared in Janux Therapeutics | Novel T Cell Immunotherapies job postings in the last six months.
How modern is the Janux Therapeutics | Novel T Cell Immunotherapies tech stack?
Janux Therapeutics | Novel T Cell Immunotherapies scores 51 out of 100 (Established). The score averages how current each technology in the stack is and adds weight for AI adoption. AI technologies in the stack: 0; legacy ones: 0.
How does Alion know the Janux Therapeutics | Novel T Cell Immunotherapies tech stack?
Alion reads every job posting Janux Therapeutics | Novel T Cell Immunotherapies publishes and tags the technologies each one names. The figures on this page count the 12 postings of the last 12 months and were updated on Oct 30, 2026.
Method and citation
Alion reads every job posting the company publishes and tags the technologies each one names. Shares count the postings of the last 12 months, open and closed; the company's own products are counted apart. How we count
Alion, "Janux Therapeutics | Novel T Cell Immunotherapies tech stack: 12 technologies from 12 job postings", as of Oct 30, 2026. https://alion.io/company/januxrx/technologies